Eli Lilly and Co Newsroom

Why Eli Lilly Is a Buy After Earnings. The Stock Got an Upgrade. -- Barrons.com

Barron'sAug 12 14:21 ET · Ratings

Berenberg Bank Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,050

Moomoo News51minutes ago · Ratings

Lilly Opens State-of-the-art Research and Development Center in the Boston Seaport

Eli Lilly & Co.Aug 13 00:00 ET

Technology giants are still the "darlings" of Wall Street investment banks! BlackRock Q2 heavily favored Microsoft, Nvidia, while Morgan Stanley aggressively bought Chinese concept stocks.

The position report of "crocodiles" has just been released!

Gelonghui Finance01:07 ET

Express News | Eli Lilly : Berenberg Raises Target Price to $1050 From $1000

Reuters00:59 ET

Eli Lilly and Co To Go Ex-Dividend On August 15th, 2024 With 1.3 USD Dividend Per Share

Moomoo News21:00 ET

DBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,060

Moomoo News14:32 ET · Ratings

Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 10 Years

Benzinga14:00 ET

Lilly, Uber Among the Biggest Recent Winners of the Beat-and-raise Game in the Stock Market

MarketWatchAug 13 11:31 ET

VOO Vs. VTI: Here Are The Key Differences Between Vanguard US Stock Market ETFs Investors Should Know

BenzingaAug 13 08:45 ET

Today's Analyst Rating | Apple Price Target Raised to $255 by Citi, Microsoft Price Target Raised to $500 by BMO Capital

Moomoo NewsAug 13 08:23 ET · Ratings

Eli Lilly Opens R&D Center in Boston Seaport

Seeking AlphaAug 13 08:09 ET

Express News | Lilly Opens State-of-the-Art Research and Development Center in the Boston Seaport

ReutersAug 13 08:00 ET

Deutsche Bank praises Eli Lilly and Co (LLY.US) as a "high-growth unicorn", with a target price skyrocketing to $1025.

Deutsche Bank has upgraded its rating on Eli Lilly and Co (LLY.US) from "hold" to "buy" with a target price increase from $725 to $1025.

Zhitong FinanceAug 13 02:52 ET

Should Investors Buy Eli Lilly's (LLY) Stock After Strong Q2 Results?

Zacks Aug 12 17:20 ET

Express News | Eli Lilly Files Pricing Term Sheet Related to Offering of Five-Part $5 Bln Aggregate Principal Amount of Notes - SEC Filing

ReutersAug 12 16:57 ET

Don't Forget This Startup's Weight-Loss Pill, Analyst Says -- Barrons.com

Barron'sAug 12 16:08 ET · Ratings

Weight Loss Drugs Like Ozempic, Zepbound May Reduce Cancer Risks, Studies Suggest

BenzingaAug 12 13:37 ET

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaAug 12 13:35 ET

Eli Lilly Tapping Bond Market for Morphic Deal -- Market Talk

WSJAug 12 12:39 ET